These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 15767045)
1. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors. Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045 [TBL] [Abstract][Full Text] [Related]
2. Adrenocortical tumorigenesis in transgenic mice: the role of luteinizing hormone receptor and transcription factors GATA-4 and GATA-61. Rahman NA; Kiiveri S; Siltanen S; Levallet J; Kero J; Lensu T; Wilson DB; Heikinheimo MT; Huhtaniemi IT Reprod Biol; 2001 Jul; 1(1):5-9. PubMed ID: 14666170 [TBL] [Abstract][Full Text] [Related]
3. Transcription factor GATA-4 is a marker of anaplasia in adrenocortical neoplasms of the domestic ferret (Mustela putorius furo). Peterson RA; Kiupel M; Bielinska M; Kiiveri S; Heikinheimo M; Capen CC; Wilson DB Vet Pathol; 2004 Jul; 41(4):446-9. PubMed ID: 15232151 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex. Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940 [TBL] [Abstract][Full Text] [Related]
5. GATA transcription factors in adrenal development and tumors. Parviainen H; Kiiveri S; Bielinska M; Rahman N; Huhtaniemi IT; Wilson DB; Heikinheimo M Mol Cell Endocrinol; 2007 Feb; 265-266():17-22. PubMed ID: 17207921 [TBL] [Abstract][Full Text] [Related]
6. Nestin as a marker in the classification of adrenocortical tumors. Lachenmayer A; Lichtenauer UD; Cox T; Schott M; Malendowicz LK; Goretzki PE; Cupisti K; Scherbaum WA; Bornstein SR; Willenberg HS Horm Metab Res; 2009 May; 41(5):397-401. PubMed ID: 19294612 [TBL] [Abstract][Full Text] [Related]
7. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281 [TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of childhood adrenocortical tumors. West AN; Neale GA; Pounds S; Figueredo BC; Rodriguez Galindo C; Pianovski MA; Oliveira Filho AG; Malkin D; Lalli E; Ribeiro R; Zambetti GP Cancer Res; 2007 Jan; 67(2):600-8. PubMed ID: 17234769 [TBL] [Abstract][Full Text] [Related]
9. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms. Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646 [TBL] [Abstract][Full Text] [Related]
10. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors. Barzon L; Pacenti M; Masi G; Stefani AL; Fincati K; Palù G Oncology; 2005; 68(4-6):414-21. PubMed ID: 16020971 [TBL] [Abstract][Full Text] [Related]
11. Reciprocal changes in the expression of transcription factors GATA-4 and GATA-6 accompany adrenocortical tumorigenesis in mice and humans. Kiiveri S; Siltanen S; Rahman N; Bielinska M; Lehto VP; Huhtaniemi IT; Muglia LJ; Wilson DB; Heikinheimo M Mol Med; 1999 Jul; 5(7):490-501. PubMed ID: 10449810 [TBL] [Abstract][Full Text] [Related]
12. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease. de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999 [TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma-related oncogene is highly expressed in developing, normal, and adenomatous adrenal tissue but not in aggressive adrenocortical carcinomas. Sarkaria IS; Stojadinovic A; Talbot SG; Hoos A; Dudas ME; Brennan MF; Ghossein RA; Singh B Surgery; 2004 Dec; 136(6):1122-8. PubMed ID: 15657565 [TBL] [Abstract][Full Text] [Related]
14. Transcription factors GATA-4 and GATA-6 in human adrenocortical tumors. Kiiveri S; Liu J; Heikkilä P; Arola J; Lehtonen E; Voutilainen R; Heikinheimo M Endocr Res; 2004 Nov; 30(4):919-23. PubMed ID: 15666845 [TBL] [Abstract][Full Text] [Related]
15. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055 [TBL] [Abstract][Full Text] [Related]
17. IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours. Schmitt A; Saremaslani P; Schmid S; Rousson V; Montani M; Schmid DM; Heitz PU; Komminoth P; Perren A Histopathology; 2006 Sep; 49(3):298-307. PubMed ID: 16918977 [TBL] [Abstract][Full Text] [Related]
18. DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions. Blanes A; Diaz-Cano SJ Hum Pathol; 2006 Oct; 37(10):1295-303. PubMed ID: 16949934 [TBL] [Abstract][Full Text] [Related]
19. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas. Iino K; Sasano H; Yabuki N; Oki Y; Kikuchi A; Yoshimi T; Nagura H Mod Pathol; 1997 Sep; 10(9):901-7. PubMed ID: 9310953 [TBL] [Abstract][Full Text] [Related]
20. DAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesis. Reincke M; Beuschlein F; Lalli E; Arlt W; Vay S; Sassone-Corsi P; Allolio B J Clin Endocrinol Metab; 1998 Jul; 83(7):2597-600. PubMed ID: 9661652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]